Welcome to our dedicated page for Flora Growth news (Ticker: FLGC), a resource for investors and traders seeking the latest updates and insights on Flora Growth stock.
Flora Growth Corp. (NASDAQ: FLGC), which has obtained shareholder approval to rebrand as ZeroStack, generates news that reflects its transition into a decentralized AI treasury company and its ongoing role as a global pharmaceutical distributor. Company announcements emphasize its strategy of accumulating $0G, the native cryptocurrency of the 0G AI infrastructure project, and its intention to position itself as a publicly listed 0G treasury.
Recent news releases highlight several themes. Flora has reported multiple private placement transactions involving common shares, pre-funded warrants, common share purchase warrants and convertible notes, with proceeds and tokens earmarked for its digital asset treasury strategy linked to $0G. The company has also announced specific purchases of $0G tokens, describing these as milestones in its mission to provide equity-based exposure to decentralized AI.
Corporate governance and capital markets developments are another recurring news topic. Flora has issued updates on its 2025 Annual and Special Meeting of Shareholders and a subsequent Special Meeting, where shareholders voted on director elections, amendments to the 2022 Incentive Compensation Plan, a share consolidation authority, a forward share split authority, the name change to ZeroStack, and approvals related to private placement issuances. The company has also reported on its 1-for-39 share consolidation and its successful effort to regain compliance with Nasdaq’s minimum bid price requirement.
Operational and strategic updates appear in news about Flora’s appointment of BitGo Trust Company, Inc. as custodian for its $0G treasury and its establishment of a crypto portfolio that includes Ethereum, Solana, Sui and Ripple. Other communications discuss its pharmaceutical distribution activities in Europe and its interest in German cannabis regulatory developments. Investors and observers can use this news feed to follow how Flora’s decentralized AI treasury strategy, financing activities, governance decisions and pharmaceutical distribution initiatives evolve over time.
Flora Growth Corp. (NASDAQ: FLGC) has expanded its market reach into the UK and Costa Rica, fulfilling initial orders from new distributors. The company’s Kasa Wholefoods division has shipped Mambe juices to Central America and products from its Mind Naturals, Almost Virgin, and Mambe brands to the UK. This marks Flora's first shipment of CBD products into Europe. The CEO, Luis Merchan, emphasized the significance of these milestones as part of Flora's strategy for international growth.
Flora Growth Corp. (NASDAQ: FLGC) successfully completed its initial public offering, selling 3,333,333 common shares at $5.00 each, resulting in gross proceeds of $16,666,665. The shares began trading on the Nasdaq Capital Market on May 11, 2021. Boustead Securities, LLC acted as the sole underwriter and has an option to purchase an additional 500,000 shares. The funds raised will support Flora's strategy of leveraging cost-effective cultivation practices for its cannabis-derived products and enhance its market presence in sectors such as cosmetics and food and beverage.
Flora Growth Corp. (NASDAQ: FLGC) announced its initial public offering (IPO) of 3,333,333 shares at $5.00 per share, yielding gross proceeds of approximately $16.67 million. The shares begin trading on Nasdaq under the symbol "FLGC." The offering, managed by Boustead Securities, includes an overallotment option for an additional 500,000 shares. Closing is anticipated on May 13, 2021, subject to customary conditions. Flora aims to leverage its outdoor cultivation practices for cannabis-derived products across various sectors, including cosmetics and food.